Endocrine Controls of Skin Aging
Endocrine Reviews · 09.05.2025 · 46 (3) · 349-375
DOI: 10.1210/endrev/bnae034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 25.02.2025. Verfasst von Markus Böhm und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Münster, Münster 48149, Germany. Hauptthemen laut MEDLINE: Skin Aging, Endocrine System, Hormones. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 392 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Frost Scholarship, University of Miami.
Abstract (Originalsprache)
Skin is the largest organ of the human body and undergoes both intrinsic (chronological) and extrinsic aging. While intrinsic skin aging is driven by genetic and epigenetic factors, extrinsic aging is mediated by external threats such as UV irradiation or fine particular matters, the sum of which is referred to as exposome. The clinical manifestations and biochemical changes are different between intrinsic and extrinsic skin aging, albeit overlapping features exist, eg, increased generation of reactive oxygen species, extracellular matrix degradation, telomere shortening, increased lipid peroxidation, or DNA damage. As skin is a prominent target for many hormones, the molecular and biochemical processes underlying intrinsic and extrinsic skin aging are under tight control of classical neuroendocrine axes. However, skin is also an endocrine organ itself, including the hair follicle, a fully functional neuroendocrine “miniorgan.” Here we review pivotal hormones controlling human skin aging focusing on IGF-1, a key fibroblast-derived orchestrator of skin aging, of GH, estrogens, retinoids, and melatonin. The emerging roles of additional endocrine players, ie, α-melanocyte-stimulating hormone, a central player of the hypothalamic-pituitary-adrenal axis; members of the hypothalamic-pituitary-thyroid axis; oxytocin, endocannabinoids, and peroxisome proliferator-activated receptor modulators, are also reviewed. Until now, only a limited number of these hormones, mainly topical retinoids and estrogens, have found their way into clinical practice as anti-skin aging compounds. Further research into the biological properties of endocrine players or its derivatives may offer the development of novel senotherapeutics for the treatment and prevention of skin aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Münster, Münster 48149, Germany.
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester M13 9PL, UK.
- CUTANEON-Skin & Hair Innovations, 22335 Hamburgyi, Germany.
- CUTANEON-Skin & Hair Innovations, 13125 Berlin, Germany.
- Department of Dermatology and Allergic Diseases, Ulm University, 89081 Ulm, Germany.
ORCID-Profile: Markus Böhm
Förderung
- Deutsche Forschungsgemeinschaft
- Frost Scholarship
- University of Miami
- DFG
- Collaborative Research Centre
- Graduate Training Group GRK 1789
- CRC1149
Zitieren
APA
Böhm, M., Stegemann, A., Paus, R., Kleszczyński, K., Maity, P., Wlaschek, M., & Scharffetter-Kochanek, K. (2025). Endocrine Controls of Skin Aging. Endocrine Reviews, 46(3), 349-375. https://doi.org/10.1210/endrev/bnae034
Vancouver
Böhm M, Stegemann A, Paus R, Kleszczyński K, Maity P, Wlaschek M, et al. Endocrine Controls of Skin Aging. Endocrine Reviews. 2025;46(3):349-375. doi:10.1210/endrev/bnae034
BibTeX
@article{Bhm2025,
author = {Böhm, Markus and Stegemann, Agatha and Paus, Ralf and Kleszczyński, Konrad and Maity, Pallab and Wlaschek, Meinhard and Scharffetter-Kochanek, Karin},
title = {Endocrine Controls of Skin Aging},
journal = {Endocrine Reviews},
year = {2025},
volume = {46},
number = {3},
pages = {349--375},
doi = {10.1210/endrev/bnae034}
}
EUVIMED